Ablative Solutions, Inc.

6203 San Ignacio Ave Ste 110, San Jose, California, United States

Also known as:

Ablative Solutions

Clinical Trials

14 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

65.0%

Phase 3

15.0%

Not Applicable

10.0%

Phase 2

10.0%

Trial Status Distribution

Active, not recruiting

65.0%

Completed

20.0%

Not yet recruiting

5.0%

Recruiting

10.0%

Clinical Trials

Trials sponsored by this organization (20)

Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)

Phase 3

Not yet recruiting

interventional

Oct 2026202 participants

The TARGET BP I

Phase 1

Recruiting

interventional

May 20241,414 participants

Study of the Effect of Kidney Denervation on Blood Pressure in Subjects with High Blood Pressure

Phase 1

Active, not recruiting

Jul 20211,500 participants

Study of the Effect of Kidney Denervation on Blood Pressure in Subjects with High Blood Pressure

Phase 1

Active, not recruiting

Nov 20201,500 participants

Study of the Effect of Kidney Denervation on Blood Pressure in Subjects with High Blood Pressure

Phase 1

Active, not recruiting

Feb 2020600 participants

Study of the Effect of Kidney Denervation on Blood Pressure in Subjects with High Blood Pressure

Phase 1

Active, not recruiting

interventional

Sep 2019600 participants

Study of the Effect of Kidney Denervation on Blood Pressure in Subjects with High Blood Pressure

Phase 1

Active, not recruiting

Aug 2019600 participants

TARGET BP I Clinical Trial

Phase 3

Active, not recruiting

interventional

Jul 2019300 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations